AA
ONC

ALPS Advisors’s BeOne Medicines Ltd ONC Stock Holding History

ALPS Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-55,678
Closed -$9.35M – 971
2018
Q1 		$9.35M Buy
55,678
+5,296
+11% +$717K 0.07% 107
2017
Q4 		$4.92M Buy
50,382
+8,643
+21% +$791K 0.03% 142
2017
Q3 		$4.32M Buy
41,739
+5,732
+16% +$427K 0.03% 148
2017
Q2 		$1.62M Buy
+36,007
New +$1.42M 0.01% 196

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

ALPS Advisors's ONC Position: Q2 2018 in Review

ALPS Advisors sold out of BeOne Medicines Ltd (ONC) in Q2 2018, closing a stake of 55,678 shares — an estimated $9.35M sold.

ALPS Advisors first reported a position in ONC in Q2 2017 and held it in 4 quarters. The position peaked at $9.35M in Q1 2018. 128 funds tracked by Wall St. Rank hold ONC as of Q2 2018.

  • ALPS Advisors reported no remaining BeOne Medicines Ltd position as of Q2 2018 after selling out during the quarter.
  • ALPS Advisors sold 55,678 BeOne Medicines Ltd shares in Q2 2018, an estimated $9.35M.
  • ALPS Advisors first reported a position in BeOne Medicines Ltd in Q2 2017 and held it in 4 quarters.
  • ALPS Advisors's BeOne Medicines Ltd position peaked at $9.35M in Q1 2018.
  • 128 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2018.

Based on ALPS Advisors's 13F filing for Q2 2018, filed 25 Jul 2018.